Artisan Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Artisan Partners’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-64,554	Closed	-$5.15M	–	344
2022 Q2	$5.15M	Sell	64,554 -192,691	-75%	-$18.2M	0.01%	300
2022 Q1	$27.1M	Sell	257,245 -257,576	-50%	-$25.1M	0.04%	273
2021 Q4	$55.5M	Buy	514,821 +38,994	+8%	+$4.25M	0.07%	239
2021 Q3	$52.1M	Sell	475,827 -5,987	-1%	-$622K	0.06%	238
2021 Q2	$45.1M	Sell	481,814 -4,672	-1%	-$430K	0.05%	247
2021 Q1	$44.8M	Sell	486,486 -29,412	-6%	-$2.48M	0.06%	260
2020 Q4	$37.7M	Buy	515,898 +363,639	+239%	+$27M	0.05%	272
2020 Q3	$11.8M	Buy	+152,259	New	+$10.5M	0.02%	299

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Artisan Partners's HZNP Position: Q3 2022 in Review

Artisan Partners sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 64,554 shares — an estimated $5.15M sold.

Artisan Partners first reported a position in HZNP in Q3 2020 and held it in 8 quarters. The position peaked at $55.5M in Q4 2021. 529 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

Artisan Partners reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
Artisan Partners sold 64,554 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $5.15M.
Artisan Partners first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 8 quarters.
Artisan Partners's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $55.5M in Q4 2021.
529 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Artisan Partners's 13F filing for Q3 2022, filed 10 Nov 2022.